Results 141 to 150 of about 26,572 (220)

Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1. [PDF]

Front Neurosci
Zafarullah M, Kamali T, Hagerman KA, Ghiglieri L, Duong T, Wang E, Sampson JB, Day JW.   +7 more
europepmc   +1 more source

The blind men and the elephant: recognising the multisystem symptoms of myotonic dystrophy type 1. [PDF]

Orphanet J Rare Dis
Leeuwenberg KE, Bruijnes JE, Karnebeek L, Smulders F, Altena-Rensen S, Gorissen-Brouwers CML, Klinkenberg S, Faber CG, Braakman H, Mul K.   +9 more
europepmc   +1 more source

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study. [PDF]

PLoS One
Mul K, Eichinger K, Hung M, Sansone VA, Gagnon C, Subramony S, Roxburgh RH, Hamel J, Statland JM, Elsheikh B, Turner C, Sampson J, Ragole T, Matthews E, Schoser B, Swenson A, Laverty C, Shieh P, Greene EP, Takahashi M, Wicklund M, Dekdebrun J, Raymond J, DeSpain E, Thornton CA, Johnson NE, Myotonic Dystrophy Clinical Research Network.   +26 more
europepmc   +1 more source

Spectrum of Cancers and Their Prognosis Among Patients With Myotonic Dystrophy.

JAMA Netw Open
Gadalla SM, McNeel TS, Wheeler W, Alsaggaf R, Hameed B, Avantsa S, Ahmadzada M, Pfeiffer RM.   +7 more
europepmc   +1 more source

Evaluation of echocardiography monitoring in myotonic dystrophy type 1 patients. [PDF]

Front Cardiovasc Med
Bovenkerk DSH, Janssen CEW, Van den Heuvel FMA, Joosten IBT, Den Uijl D, Van Engelen BGM, Van Kuijk SMJ, Nijveldt R, Evertz R, Faber CG, Vernooy K, Bijvoet GP.   +11 more
europepmc   +1 more source

Measuring Myotonia: Normative Values and Comparison with Myotonic Dystrophy Type 1. [PDF]

Neurol Int
Sipos A, Árvai M, Varga D, Ruszin-Perecz B, Janszky J, Hajdú N, Pál E.   +6 more
europepmc   +1 more source

Myotonic Dystrophy [PDF]

, 2020
openaire   +1 more source

Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1. [PDF]

Mol Ther
Tomassy GS, Fan W, Cao S, Luo Z, Magli A, Zhang T, Boyle K, Jackson R, Richards B, Liu D, Rapaport F, Khader S, Pfister EL, O'Riordan C, Frederick A, Sullivan J, Cao J, Nageswara Rao K, Assaf BT, Goulet M, Mueller C.   +20 more
europepmc   +1 more source

Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period. [PDF]

J Neurol
Krieger B, Schneider-Gold C, Genç E, Güntürkün O, Prehn C, Bellenberg B, Lukas C.   +6 more
europepmc   +1 more source

Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. [PDF]

Genes (Basel)
Cerecedo-Zapata CM, Guerra-Grajeda A, Márquez-Quiróz LC, Arciga-Portela P, Escobar-Cedillo RE, Jiménez-Gutiérrez GE, Pérez-Méndez ÓA, Velasco-Flores JS, Barredo-Prieto BA, Leyva-García N, Cisneros B, Murillo-Melo NM, Magaña JJ.   +12 more
europepmc   +1 more source